SBC Medical Group (SBC)
NASDAQ: SBC
· Real-Time Price · USD
4.22
0.16 (3.94%)
At close: Aug 15, 2025, 10:03 AM
SBC Medical Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | 188.19M | 197.94M | 205.42M | 223.34M | 217.54M | 205.44M | 193.54M | 131.19M | 83.91M | 42.91M |
Cost of Revenue | 43.81M | 43.67M | 49.37M | 57.8M | 61.73M | 57.13M | 56.24M | 37.26M | 23.48M | 14.4M |
Gross Profit | 144.38M | 154.26M | 156.05M | 165.55M | 155.8M | 148.31M | 137.3M | 93.94M | 60.44M | 28.52M |
Operating Income | 57.31M | 70.04M | 70.3M | 89.58M | 95.76M | 84.04M | 70.66M | 46.67M | 26.65M | 11.08M |
Interest Income | 51.14K | 39.9K | 2.25K | 37.69K | 39.97K | 28.33K | 10.64K | 10.23K | n/a | n/a |
Pretax Income | 64.16M | 77.71M | 73.46M | 90.96M | 98.92M | 88.51M | 73.58M | 50.01M | 28.94M | 12.27M |
Net Income | 33.33M | 49.36M | 46.61M | 54.42M | 59.94M | 52.13M | 39.37M | 25.03M | 16.67M | 6M |
Selling & General & Admin | 70.96M | 67.81M | 69.94M | 75.39M | 59.58M | 63.95M | 66.23M | 46.89M | 33.44M | 17.25M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 16.11M | 16.41M | 15.81M | 580.82K | 457.72K | 317.03K | 409.03K | 380.77K | 352.25K | 192.05K |
Operating Expenses | 87.07M | 84.22M | 85.75M | 75.97M | 60.04M | 64.26M | 66.64M | 47.27M | 33.79M | 17.44M |
Interest Expense | 73.73K | 31.5K | 28.3K | 23.81K | 22.32K | 14.9K | 11.89K | 3.98K | n/a | n/a |
Selling & Marketing Expenses | 2.53M | 3.38M | 3.4M | 2.18M | 1.56M | 711.63K | n/a | n/a | n/a | n/a |
Cost & Expenses | 130.88M | 127.89M | 135.11M | 133.77M | 121.77M | 121.39M | 122.88M | 84.52M | 57.27M | 31.84M |
Income Tax Expense | 30.84M | 28.27M | 26.77M | 36.59M | 39.33M | 37.61M | 35.02M | 25.68M | 12.67M | 5.86M |
Shares Outstanding (Basic) | 103.51M | 103.28M | 102.75M | 95.1M | 95.1M | 7.95M | 100.74M | 100.74M | 7.95M | n/a |
Shares Outstanding (Diluted) | 103.51M | 103.28M | 102.75M | 95.1M | 95.1M | 7.95M | 100.74M | 100.74M | 7.95M | n/a |
EPS (Basic) | 0.33 | 0.50 | 2.65 | 2.73 | 2.78 | 3.92 | 1.56 | 1.42 | 1.34 | n/a |
EPS (Diluted) | 0.33 | 0.50 | 2.65 | 2.73 | 2.78 | 3.92 | 1.56 | 1.42 | 1.34 | n/a |
EBITDA | 67.42M | 81.34M | 77.48M | 96.61M | 106.84M | 97.89M | 83.54M | 57.41M | 33.05M | 13.87M |
EBIT | 64.23M | 77.74M | 73.48M | 90.99M | 98.95M | 87.42M | 71.29M | 47.72M | 26.65M | 11.08M |
Depreciation & Amortization | 3.18M | 3.41M | 3.8M | 5.43M | 7.7M | 10.47M | 12.25M | 9.69M | 6.4M | 2.8M |